Firm's Discontinued Hair Volume Claims Keep Growing Back; NAD Alerts FTC
This article was originally published in The Tan Sheet
New Nordic's seeming refusal to dispense with hair-growth claims in ads for its Hair Volume supplement, despite repeated promises to the National Advertising Division, has resulted in a referral to the Federal Trade Commission.
You may also be interested in...
With FDA scrutinizing the marketplace for cosmetics promoted as drugs, and a clear cautionary statement from the agency about topical products marketed as hair growers or hair-loss preventers, beauty firms have little choice but to incorporate approved OTC drug ingredients in such products. P&G’s professional hair-care brand NIOXIN has done just that with its new Advanced Thinning range featuring minoxidil.
The National Advertising Division advises New Nordic USA to discontinue claims suggesting that its Hair Volume dietary supplement strengthens hair and even reverses genetic pattern baldness in women. The bulk of the advertiser’s submitted evidence was either insufficient or irrelevant to the claims in question.
Cannabidiol (CBD) represents an intriguing opportunity for cosmetics, without the statutory obstacles faced by food and dietary supplement companies. Cosmetics marketers are taking advantage, but the FDA’s recent warning letter blitz is a reminder that CBD-infused beauty products are bound by the same rules that apply to other cosmetics.